Anangisye I Malabeja

Suggest Changes
Learn More
BACKGROUND RTS,S/AS01E is the lead candidate malaria vaccine. We recently showed efficacy against clinical falciparum malaria in 5-17 month old children, during an average of 8 months follow-up. We(More)
  • 1